VolitionRx Limited Increase (Decrease) in Accounts Receivable
VolitionRx Limited (VNRX) reported Increase (Decrease) in Accounts Receivable of -$40.45 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- VolitionRx Limited increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $25.11K, a 1321.22% increase year-over-year.
- VolitionRx Limited increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$65.57K, a 184.87% decline year-over-year.
- VolitionRx Limited increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $8.72K.
- VolitionRx Limited increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $119.49K, a 18.35% decline year-over-year.
- VolitionRx Limited increase (decrease) in accounts receivable for fiscal 2025 was $207.23K.
- VolitionRx Limited increase (decrease) in accounts receivable for fiscal 2024 was -$132.04K, a 177.83% decline from fiscal 2023.
- VolitionRx Limited increase (decrease) in accounts receivable for fiscal 2023 was $169.67K.
- VolitionRx Limited increase (decrease) in accounts receivable for fiscal 2022 was -$72.61K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed | Increase (Decrease) in Accounts Receivable 20 month | Increase (Decrease) in Accounts Receivable 23 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$40.45K 10-Q · filed 2026-08-13 | -$31.73K derived: sum of 3 quarters · filed 2026-08-13 | $87.76K derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2026-03-31 | -$65.57K 10-Q · filed 2026-05-14 | -$56.84K derived: sum of 2 quarters · filed 2026-05-14 | $62.65K derived: sum of 3 quarters · filed 2026-05-14 | $64.41K derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-12-31 | $8.72K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $128.21K derived: sum of 2 quarters · filed 2026-03-31 | $129.98K derived: sum of 3 quarters · filed 2026-08-13 | $207.23K 10-K · filed 2026-03-31 | ||||||
| 2025-09-30 | $119.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $121.25K derived: sum of 2 quarters · filed 2026-08-13 | $198.51K 10-Q · filed 2025-11-13 | -$3.53K derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-06-30 | $1.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $79.02K 10-Q · filed 2026-08-13 | -$123.01K derived: sum of 3 quarters · filed 2026-08-13 | $23.34K derived: sum of 4 quarters · filed 2026-08-13 | ||||||
| 2025-03-31 | $77.26K 10-Q · filed 2026-05-14 | -$124.78K derived: sum of 2 quarters · filed 2026-05-14 | $21.57K derived: sum of 3 quarters · filed 2026-05-14 | $51.54K derived: sum of 4 quarters · filed 2026-05-14 | ||||||
| 2024-12-31 | -$202.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$55.69K derived: sum of 2 quarters · filed 2026-03-31 | -$25.72K derived: sum of 3 quarters · filed 2026-03-31 | -$132.04K 10-K · filed 2026-03-31 | ||||||
| 2024-09-30 | $146.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $176.32K derived: sum of 2 quarters · filed 2025-11-13 | $69.99K 10-Q · filed 2025-11-13 | $205.22K derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2024-06-30 | $29.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$76.36K 10-Q · filed 2025-08-14 | $76.36K 10-Q · filed 2024-08-14 | $58.87K derived: sum of 3 quarters · filed 2025-08-14 | $289.80K derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | -$106.33K 10-Q · filed 2025-05-15 | $28.90K derived: sum of 2 quarters · filed 2025-05-15 | $259.83K derived: sum of 3 quarters · filed 2025-05-15 | -$55.25K derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | $135.22K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $366.15K derived: sum of 2 quarters · filed 2025-03-31 | $51.07K derived: sum of 3 quarters · filed 2025-03-31 | $169.67K 10-K · filed 2025-03-31 | -$169.67K 10-K · filed 2024-03-25 | |||||
| 2023-09-30 | $230.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$84.15K derived: sum of 2 quarters · filed 2024-11-14 | $34.44K 10-Q · filed 2024-11-14 | -$31.21K derived: sum of 4 quarters · filed 2024-11-14 | ||||||
| 2023-06-30 | -$315.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$196.49K 10-Q · filed 2024-08-14 | $196.49K 10-Q · filed 2023-08-14 | -$262.14K derived: sum of 3 quarters · filed 2024-08-14 | -$265.13K derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $118.59K 10-Q · filed 2024-05-13 | $52.94K derived: sum of 2 quarters · filed 2024-05-13 | $49.95K derived: sum of 3 quarters · filed 2024-05-13 | -$13.88K derived: sum of 4 quarters · filed 2024-05-13 | ||||||
| 2022-12-31 | -$65.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$68.65K derived: sum of 2 quarters · filed 2024-03-25 | -$132.47K derived: sum of 3 quarters · filed 2024-03-25 | -$72.61K 10-K · filed 2024-03-25 | ||||||
| 2022-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$66.82K derived: sum of 2 quarters · filed 2023-11-14 | -$6.96K 10-Q · filed 2023-11-14 | -$31.89K derived: sum of 4 quarters · filed 2023-11-14 | ||||||
| 2022-06-30 | -$63.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$3.96K 10-Q · filed 2023-08-14 | $3.96K 10-Q · filed 2022-08-10 | -$28.89K derived: sum of 3 quarters · filed 2023-08-14 | -$7.79K derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $59.86K 10-Q · filed 2023-05-10 | -$59.86K 10-Q · filed 2022-05-11 | $34.94K derived: sum of 2 quarters · filed 2023-05-10 | $56.03K derived: sum of 3 quarters · filed 2023-05-10 | $61.59K derived: sum of 4 quarters · filed 2023-05-10 | |||||
| 2021-12-31 | -$24.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$3.83K derived: sum of 2 quarters · filed 2023-03-15 | $1.73K derived: sum of 3 quarters · filed 2023-03-15 | -$12.51K 10-K · filed 2023-03-15 | $12.51K 10-K · filed 2022-03-30 | |||||
| 2021-09-30 | $21.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $26.65K derived: sum of 2 quarters · filed 2022-11-14 | $12.42K 10-Q · filed 2022-11-14 | -$12.42K 10-Q · filed 2021-11-10 | $20.11K derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $5.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$8.68K 10-Q · filed 2022-08-10 | -$991.00 derived: sum of 3 quarters · filed 2022-08-10 | $1.66K derived: sum of 4 quarters · filed 2022-08-10 | ||||||
| 2021-03-31 | -$14.24K 10-Q · filed 2022-05-11 | -$6.55K derived: sum of 2 quarters · filed 2022-05-11 | -$3.90K derived: sum of 3 quarters · filed 2022-05-11 | -$6.88K derived: sum of 4 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $7.69K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $10.34K derived: sum of 2 quarters · filed 2022-03-30 | $7.36K derived: sum of 3 quarters · filed 2022-03-30 | $7.12K 10-K · filed 2022-03-30 | -$7.12K 10-K · filed 2021-03-22 | |||||
| 2020-09-30 | $2.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$331.00 derived: sum of 2 quarters · filed 2021-11-10 | -$573.00 10-Q · filed 2021-11-10 | $15.46K derived: sum of 4 quarters · filed 2021-11-10 | ||||||
| 2020-06-30 | -$2.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$3.22K 10-Q · filed 2021-08-11 | $12.81K derived: sum of 3 quarters · filed 2021-08-11 | -$3.22K derived: sum of 4 quarters · filed 2021-08-11 | ||||||
| 2020-03-31 | -$242.00 10-Q · filed 2021-05-11 | $15.79K derived: sum of 2 quarters · filed 2021-05-11 | -$242.00 derived: sum of 3 quarters · filed 2021-05-11 | |||||||
| 2019-12-31 | $16.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $0.00 derived: sum of 2 quarters · filed 2021-03-22 | $0.00 10-K · filed 2021-03-22 | |||||||
| 2019-09-30 | -$16.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$16.03K 10-Q · filed 2020-11-12 | ||||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | |||||||||
| 2017-09-30 | -$12.36K 10-Q · filed 2017-11-09 | |||||||||
| 2012-06-30 | $3.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$11.71K 10-Q · filed 2013-07-29 | -$11.71K 10-Q · filed 2012-08-14 | |||||||
| 2012-03-31 | -$15.67K 10-Q · filed 2013-05-06 | -$15.67K 10-Q · filed 2012-05-15 | ||||||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | ||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |